Detalhe da pesquisa
1.
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Lancet
; 402(10419): 2295-2306, 2023 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931632
2.
Targeting Mesothelin in Solid Tumours: Anti-mesothelin Antibody and Drug Conjugates.
Curr Oncol Rep
; 25(4): 309-323, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763234
3.
Lifestyle factors and lung cancer risk among never smokers in the Canadian Partnership for Tomorrow's Health (CanPath).
Cancer Causes Control
; 33(6): 913-918, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35302182
4.
Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumors.
Invest New Drugs
; 39(4): 1001-1010, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33479856
5.
Amplifying Outcomes: Checkpoint Inhibitor Combinations in First-Line Non-Small Cell Lung Cancer.
Oncologist
; 25(1): 64-77, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31138727
6.
Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer.
Oncologist
; 25(11): 981-992, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32860288
7.
Profiling Determinants of Resting Energy Expenditure in Colorectal Cancer.
Nutr Cancer
; 72(3): 431-438, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31282744
8.
Undiagnosed cardiac deficits in non-small cell carcinoma patients in the candidate population for anti-cachexia clinical trials.
Support Care Cancer
; 27(4): 1551-1561, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30547303
9.
Correction to: Lifestyle factors and lung cancer risk among never smokers in the Canadian Partnership for Tomorrow's Health (CanPath).
Cancer Causes Control
; 33(6): 919, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35435535
10.
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol
; 17(12): 1643-1652, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27751847
11.
Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial.
Lancet Oncol
; 16(4): 447-56, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25800891
12.
A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumors.
Invest New Drugs
; 33(3): 603-10, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25762000
13.
Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancer.
Invest New Drugs
; 32(5): 1036-45, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24853074
14.
A phase I, dose-escalation trial of continuous- and pulsed-dose afatinib combined with pemetrexed in patients with advanced solid tumors.
Invest New Drugs
; 32(6): 1226-35, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25037863
15.
Effects of low-fat and high-fat meals on steady-state pharmacokinetics of lapatinib in patients with advanced solid tumours.
Invest New Drugs
; 32(3): 481-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24346280
16.
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.
Nat Med
; 30(3): 716-729, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38351187
17.
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer.
Curr Oncol
; 30(7): 6289-6315, 2023 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37504325
18.
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC.
Curr Oncol
; 30(7): 6473-6496, 2023 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37504336
19.
Lorlatinib Effectiveness and Quality-of-Life in Patients with ALK-Positive NSCLC Who Had Failed Second-Generation ALK Inhibitors: Canadian Real-World Experience.
Curr Oncol
; 30(7): 6559-6574, 2023 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37504341
20.
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process.
Curr Oncol
; 30(12): 10363-10384, 2023 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38132389